| Literature DB >> 32617310 |
Guanyu Zhou1, Ying Zhou1, Cejun Zhong1, Hui Ye1, Zhenzhen Liu1, Yanbin Liu1, Guangmin Tang1, Junyan Qu1, Xiaoju Lv1.
Abstract
BACKGROUND: Fever of unknown origin (FUO) is commonly defined as fever higher than 38.3 °C on several occasions during at least 3 weeks with uncertain diagnosis after a number of obligatory investigations. It is a special type of fever and a common disease in internal medicine. However, due to its complex etiology, lack of characteristic clinical manifestations, and insufficient laboratory examination indicators, it often baffles clinicians in diagnosis. We herein present a study of the etiological factors and clinical features of classic fever of unknown origin (FUO) to provide help for related clinical diagnosis and treatment.Entities:
Keywords: Fever of unknown origin (FUO); etiology; retrospective analysis
Year: 2020 PMID: 32617310 PMCID: PMC7327343 DOI: 10.21037/atm-20-3875
Source DB: PubMed Journal: Ann Transl Med ISSN: 2305-5839
Causes of the 1,641 cases of FUO
| Cause of FUO | No. of cases | Percentage (%) |
|---|---|---|
| Infectious diseases | 799 | 48.69 |
| Bacterial infections | 591 | 36.01 |
| Tuberculosis | 320 | 19.50 |
| Septicemia | 117 | 7.13 |
| Infective endocarditis | 47 | 2.86 |
| Biliary tract infection | 32 | 1.95 |
| Pulmonary infection | 15 | 0.91 |
| Urinary tract infection | 13 | 0.79 |
| Peritonitis | 11 | 0.67 |
| Liver abscess | 7 | 0.43 |
| Brucellosis | 7 | 0.43 |
| Abdominal abscess | 6 | 0.36 |
| Renal abscess | 5 | 0.30 |
| Non-tuberculosis mycobacteria infection | 4 | 0.24 |
| Chronic tonsillitis | 3 | 0.18 |
| Typhoid | 3 | 0.18 |
| Retropharyngeal abscess | 1 | 0.06 |
| Viral infections | 168 | 10.24 |
| Epstein-Barr virus | 83 | 5.06 |
| Cytomegalovirus | 33 | 2.01 |
| Herpes simplex virus | 12 | 0.73 |
| Viral meningitis | 9 | 0.55 |
| HIV | 8 | 0.49 |
| Rubella | 3 | 0.18 |
| Parvovirus | 1 | 0.06 |
| Other viral infections | 19 | 1.16 |
| Invasive fungal infections | 15 | 0.91 |
| Pulmonary aspergillosis | 7 | 0.43 |
| Histoplasmosis | 5 | 0.30 |
| Aspergillus sinusitis | 3 | 0.18 |
| Parasitic infections | 16 | 0.98 |
| Kala-azar | 11 | 0.67 |
| Paragonimiasis | 2 | 0.12 |
| Toxoplasma gondii | 2 | 0.12 |
| Malaria | 1 | 0.06 |
| Other pathogenic infections | 9 | 0.55 |
| Mycoplasmal pneumonia | 7 | 0.43 |
| Tsutsugamushi | 2 | 0.12 |
| Connective tissue diseases | 316 | 19.26 |
| AOSD | 89 | 5.42 |
| Systemic lupus erythematosus | 31 | 1.89 |
| Systemic vasculitis | 29 | 1.77 |
| Necrotizing lymphadenitis | 28 | 1.71 |
| Sjogren syndrome | 23 | 1.40 |
| Polymyalgia rheumatica | 12 | 0.73 |
| Dermatomyositis | 12 | 0.73 |
| Rheumatoid arthritis | 11 | 0.67 |
| Erythema nodosum | 9 | 0.55 |
| Reactive arthritis | 8 | 0.49 |
| Ankylosing spondylitis | 5 | 0.30 |
| Autoimmune liver disease | 5 | 0.30 |
| IgG4-related diseases | 5 | 0.30 |
| Systemic sclerosis | 4 | 0.24 |
| Polymyositis | 2 | 0.12 |
| Behcet’s disease | 2 | 0.12 |
| Autoimmune encephalitis | 1 | 0.06 |
| Rheumatic fever | 1 | 0.06 |
| Mixed connective tissue disease | 18 | 1.10 |
| Undifferentiated connective tissue disease | 21 | 1.28 |
| Neoplastic diseases | 278 | 16.94 |
| Lymphoma | 143 | 8.71 |
| Leukemia | 61 | 3.72 |
| Multiple myeloma | 31 | 1.89 |
| Hepatoma | 12 | 0.73 |
| Malignant histiocytosis | 11 | 0.67 |
| Lung carcinoma | 7 | 0.43 |
| Renal carcinoma | 4 | 0.24 |
| Soft tissue sarcoma | 3 | 0.18 |
| Prostate cancer | 3 | 0.18 |
| Thyroid carcinoma | 2 | 0.12 |
| Ovarian cancer | 1 | 0.06 |
| Other diseases | 111 | 6.76 |
| Undetermined | 137 | 8.35 |
| Total | 1,641 | 100 |
FUO, fever of unknown origin; AOSD, adult-onset Still’s disease.
Percentages of causes of FUO ranked by gender
| Gender | Infectious diseases (%) | Connective tissue diseases (%) | Neoplastic diseases (%) | Other diseases (%) | Undetermined (%) | Total |
|---|---|---|---|---|---|---|
| Male | 439 (58.11) | 107 (14.13) | 127 (16.67) | 40 (5.28) | 44 (5.81) | 757 |
| Female | 360 (40.73) | 209 (23.64) | 151 (17.08) | 71 (8.03) | 93 (10.52) | 884 |
| Total | 799 (48.69) | 316 (19.26) | 278 (16.94) | 111 (6.76) | 137 (8.35) | 1,641 |
FUO, fever of unknown origin.
Percentages of causes of FUO ranked by age
| Age | Infectious diseases (%) | Connective tissue diseases (%) | Neoplastic diseases (%) | Other diseases (%) | Undetermined (%) | Total |
|---|---|---|---|---|---|---|
| <20 | 80 (45.97) | 50 (28.74) | 23 (13.22) | 10 (5.75) | 11 (6.32) | 174 |
| 20–39 | 290 (47.90) | 185 (31.20) | 49 (8.26) | 16 (2.70) | 53 (8.94) | 593 |
| 40–59 | 253 (51.01) | 34 (6.85) | 117 (23.59) | 42 (8.47) | 50 (10.08) | 496 |
| ≥60 | 176 (46.58) | 47 (12.43) | 89 (23.54) | 43 (11.37) | 23 (6.08) | 378 |
| Total | 799 (50.11) | 316 (20.07) | 278 (16.17) | 111 (4.31) | 137 (8.35) | 1,641 |
FUO, fever of unknown origin.
Figure 1The relationship between the distribution of etiology and gender in patients with fever of unknown origin.
Durations of the various cases of FUO and the percentage of each cause
| Duration of FUO (days) | Infectious diseases (%) | Connective tissue diseases (%) | Neoplastic diseases (%) | Other diseases (%) | Undetermined (%) | Total |
|---|---|---|---|---|---|---|
| 21–30 | 239 (46.96) | 135 (26.52) | 62 (12.18) | 62 (12.18) | 11 (2.16) | 509 |
| 31–60 | 230 (42.83) | 93 (17.32) | 166 (30.91) | 41 (7.64) | 7 (1.30) | 537 |
| 60–90 | 162 (59.79) | 24 (8.85) | 46 (16.97) | 8 (2.95) | 31 (11.44) | 271 |
| 91–180 | 81 (55.86) | 38 (26.21) | 4 (2.76) | 0 (0) | 22 (15.17) | 145 |
| >180 | 87 (48.60) | 26 (14.53) | 0 (0) | 0 (0) | 66 (36.87) | 179 |
| Total | 799 (48.69) | 316 (19.26) | 278 (16.94) | 111 (6.76) | 137 (8.35) | 1,641 |
FUO, fever of unknown origin.
Methods by which the diseases were diagnosed
| Type of disease | Laboratory investigation (%) | Radiographic investigation (%) | Invasive investigation (%) | Diagnostic treatment (%) | Total |
|---|---|---|---|---|---|
| Infectious diseases | 257 (32.16) | 216 (27.03) | 90 (11.26) | 236 (29.55) | 799 |
| Connective tissue diseases | 164 (51.90) | 0 (0) | 74 (23.42) | 78 (24.68) | 316 |
| Neoplastic diseases | 0 (0) | 53 (19.06) | 225 (80.94) | 0 (0) | 278 |
| Other diseases | 19 (17.12) | 27 (24.32) | 5 (4.50) | 60 (54.06) | 111 |
| Total | 440 (29.25) | 296 (19.68) | 394 (26.19) | 374 (24.88) | 1,504 |
Note: diagnostic treatment includes drug discontinuance and clinical observation.
Comparison between the clinical data of lymphoma and tuberculosis patients
| Variable | Lymphoma (n=86) | Tuberculosis (n=174) | P value |
|---|---|---|---|
| Age1 | 32 [17–67] | 33 [20–71] | 0.082 |
| Gender (male)2 | 42 [48.3%] | 91 [52.87%] | 0.394 |
| Duration of fever (days)3 | 50 [25–380] | 49 [23–100] | 0.342 |
| Highest body temperature (°C)3 | 39.0 [38.4–40.1] | 39.0 [38.3–39.8] | 0.451 |
| Type of fever4 | 0.089 | ||
| Intermittent fever | 21 | 53 | |
| Remittent fever | 42 | 104 | |
| Irregular fever | 23 | 17 | |
| Duration of fever4 | 0.063 | ||
| 6:00–12:00 | 1 | 2 | |
| 12:00–18:00 | 52 | 112 | |
| 18:00–6:00 (next day) | 23 | 41 | |
| Irregular | 10 | 19 | |
| Chills4 | 0.071 | ||
| No | 31 | 74 | |
| Yes | 55 | 100 | |
| Shivering4 | 0.195 | ||
| No | 62 | 138 | |
| Yes | 24 | 36 | |
| Peripheral lymphadenopathy4 | 0.570 | ||
| No | 67 | 131 | |
| Yes | 19 | 43 | |
| Splenomegaly4 | 0.613 | ||
| No | 69 | 129 | |
| Yes | 17 | 45 | |
| WBC (×109/L)3 | 6.27 [1.27–12.65] | 8.44 [3.22–15.02] | 0.071 |
| HB (g/L)3 | 105 [74–129] | 102 [76–132] | 0.174 |
| PLT (×109/L)3 | 211 [89–337] | 206 [81–382] | 0.067 |
| ESR (mm/h)3 | 29 [2–120] | 62 [15–120] | 0.057 |
| CRP (mg/dL)3 | 66.8 [1.73–166] | 59.2 [10.4–169] | 0.054 |
| PCT (ng/mL)3 | 0.52 [0.04–3.16] | 0.66 [0.04–4.43] | 0.192 |
| LDH (U/L)3 | 317 [162–764] | 235 [118–629] | 0.063 |
Note: 1, t-test; 2, chi-square test; 3, Mann-Whitney U test; 4, Fisher’s exact test.